Ultra High-risk Gestational Trophoblastic Neoplasia.

Hematol Oncol Clin North Am

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA; New England Trophoblastic Disease Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Dana-Farber Cancer Institute, Boston, MA, USA.

Published: December 2024

Ultra high-risk gestational trophoblastic neoplasia (GTN) refers to patients with World Health Organization prognostic risk scores of at least 13. The mortality risk for these patients averages 30%. Ultra high-risk GTN more frequently presents with higher tumor volume, liver and/or brain metastases, and very high human chorionic gonadotropin levels. The diagnostic evaluation must include a thorough evaluation for central nervous system disease. Prompt initiation of cisplatin - etoposide induction chemotherapy reduces the risks of early death. Collaborative services such as neurosurgery, radiation oncology, and interventional radiology may be required to manage hemorrhagic lesions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2024.08.015DOI Listing

Publication Analysis

Top Keywords

ultra high-risk
12
high-risk gestational
8
gestational trophoblastic
8
trophoblastic neoplasia
8
neoplasia ultra
4
neoplasia gtn
4
gtn refers
4
refers patients
4
patients health
4
health organization
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!